Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-kappa B signaling pathway with distinct mechanisms | |
Peng, Yan-min1; Zheng, Jian-bin2; Zhou, Yu-bo1![]() ![]() | |
刊名 | ACTA PHARMACOLOGICA SINICA
![]() |
2013-07 | |
卷号 | 34期号:7页码:939-950 |
关键词 | curcumin P1 anticancer agent high-throughput screen NF-kappa B HeLa cell mitochondria ROS |
ISSN号 | 1671-4083 |
DOI | 10.1038/aps.2013.2 |
文献子类 | Article |
英文摘要 | Aim: Curcumin has shown promising anticancer activity, which relies on its inhibition on NF-kappa B pathway. In this study, we characterized the pharmacological profile of a novel curcumin analog P1 and elucidate the related mechanisms. Methods: HEK293/NF-kappa B cells, stably transfected with an NF-kappa B-responsive luciferase reporter plasmid, were generated for high-throughput screen (HTS). Eight cancer cell lines, including PC3, COLO 205, HeLa cells etc. were tested. Cell viability was assessed using the sulforhodamine B (SRB) assays. Cell apoptosis was evaluated using FACS, immunocytochemistry, and Western blotting. H-2-DCFDA and MitoSOX Red were used to detect cellular and mitochondrial reactive oxygen species (ROS). The mitochondrial function was evaluated using mitochondrial oxygen consumption assay. Results: P1, a tropinone curcumin, was found in HTS targeting the NF-kappa B pathway. Its IC50 value in inhibition of TNF-alpha-induced NF-kappa B activation was 0.8 mu mol/L, whereas its IC50 values in inhibiting the growth of A549 and HeLa cells were 1.24 and 0.69 mu mol/L, respectively, which was 20- to 30-fold more potent than curcumin. The inhibition of P1 on the NF-kappa B pathway was further addressed in HeLa cells. The compound up to 10 mu mol/L did not affect the binding of NF-kappa B to DNA, but markedly inhibited NF-kappa B nuclear translocation, I kappa B degradation and I kappa B kinase phosphorylation. The compound (1 and 3 mu mol/L) concentration-dependently induced ROS generation, whereas curcumin up to 20 mu mol/L had no effect. P1-induced ROS generation was mainly localized in mitochondria, and reversed by NAC. Moreover, the compound significantly enhanced TNF-alpha-induced apoptosis. Conclusion: P1 is a novel curcumin analog with potent anticancer activities, which exerts a distinct inhibition on the NF-kappa B pathway. |
资助项目 | National Natural Science Foundation of China[91029716] ; National Natural Science Foundation of China[81021062] ; National Natural Science Foundation of China[81072667] |
WOS关键词 | ACTIVATED PROTEIN-KINASE ; REGULATED GENE-PRODUCTS ; PANCREATIC-CANCER ; TNF-ALPHA ; OXIDATIVE STRESS ; TUMOR-CELLS ; APOPTOSIS ; PROLIFERATION ; SUPPRESSION ; EXPRESSION |
WOS研究方向 | Chemistry ; Pharmacology & Pharmacy |
语种 | 英语 |
CSCD记录号 | CSCD:4874888 |
出版者 | ACTA PHARMACOLOGICA SINICA |
WOS记录号 | WOS:000321332700010 |
内容类型 | 期刊论文 |
源URL | [http://119.78.100.183/handle/2S10ELR8/277556] ![]() |
专题 | 国家新药筛选中心 中科院受体结构与功能重点实验室 新药研究国家重点实验室 |
通讯作者 | Zhou, Yu-bo |
作者单位 | 1.Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Natl Ctr Drug Screening, Shanghai 201203, Peoples R China; 2.E China Univ Sci & Technol, Sch Pharm, Shanghai 200237, Peoples R China |
推荐引用方式 GB/T 7714 | Peng, Yan-min,Zheng, Jian-bin,Zhou, Yu-bo,et al. Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-kappa B signaling pathway with distinct mechanisms[J]. ACTA PHARMACOLOGICA SINICA,2013,34(7):939-950. |
APA | Peng, Yan-min,Zheng, Jian-bin,Zhou, Yu-bo,&Li, Jia.(2013).Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-kappa B signaling pathway with distinct mechanisms.ACTA PHARMACOLOGICA SINICA,34(7),939-950. |
MLA | Peng, Yan-min,et al."Characterization of a novel curcumin analog P1 as potent inhibitor of the NF-kappa B signaling pathway with distinct mechanisms".ACTA PHARMACOLOGICA SINICA 34.7(2013):939-950. |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论